Premarket Movers | Revolution Medicines Jumps 16%; Tilray Gains 7%; Semiconductor Equipment Shares Jump With ASML Up 3%; AXT Falls 13% on Lowered Sales Outlook

Tiger Newspress
01/09

Revolution Medicines, Inc. jumped over 16% in premarket trading as Merck is in talks to buy it, the Financial Times reported on Thursday, citing people familiar with the matter.

Semiconductor equipment shares jumped in premarket trading with ASML up 3%, Lam Research up 1.3%.

AXT shares dropped after the company cut its revenue outlook, citing China's reduction of export control permits. The stock shed 13% to $22.45 in premarket trading. Through the close, shares were up nearly fivefold over the past three months.

Tilray Inc. rose 7% in premarket trading after announcing a potential rescheduling of marijuana in the U.S. could boost its medical cannabis business.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10